Sitanat M 50mg/500mg Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Sitagliptin (50mg) + Metformin (500mg)
Overview Sitanat M 50mg/500mg Tablet
Combiflex DM 50mg/500mg tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate serious diabetic complications like vision impairment and kidney disease, potentially lowering the risk of cardiovascular events like stroke or heart attack. Combiflex DM 50mg/500mg may be administered as a standalone therapy or in conjunction with other anti-diabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized, considering individual health status, glucose levels, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle choices significantly impact blood sugar control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, especially when used with insulin or sulfonylureas; prompt recognition and treatment are essential. This medication isn't suitable for all individuals. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, heart, or pancreatic conditions, as well as significant alcohol consumption. Pregnant or lactating women should consult their doctor. Interactions with other medications are possible; disclose all concurrent medications for safety evaluation. Alcohol should be minimized due to its potential to lower blood glucose. Your physician will monitor kidney function and blood sugar levels throughout the treatment period.
Primary Ingredients of Sitanat M 50mg/500mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Sitanat M 50mg/500mg Tablet
Managing Type 2 Diabetes
Major Benefits of Sitanat M 50mg/500mg Tablet:
Administer this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Sitanat M 50mg/500mg Tablet with a meal.
Common Side effects of Sitanat M 50mg/500mg Tablet:
- Decreased appetite
- Vomiting
- Upper respiratory tract infection
- Hypoglycemia (low blood glucose level)
- Abdominal bloating
- Nausea
- Diarrhea
How to use Sitanat M 50mg/500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 50mg/500mg Sitanat M Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Sitanat M 50mg/500mg Tablet works:
Sitanat M 50mg/500mg tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action optimizes blood sugar regulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sitanat M 50mg/500mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Sitanat M 50mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
The use of Sitanat M 50mg/500mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Sitanat M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Sitanat M 50mg/500mg tablet use. Physician consultation is essential. Routine kidney function monitoring is recommended during treatment.
LiverUNSAFE
Patients with liver impairment should likely refrain from using Sitanat M 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.
What if you forget to take Sitanat M 50mg/500mg Tablet :
Should you forget a Sitanat M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sitanat M 50mg/500mg Tablet
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Diabetes Management |